Business Investing in Malaria Control: Economic Returns and ... - Path
Business Investing in Malaria Control: Economic Returns and ... - Path
Business Investing in Malaria Control: Economic Returns and ... - Path
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ANNEX A. METHODS TO ASSESS THE<br />
BENEFITS OF PRIVATE-SECTOR CONTROL<br />
EFFORTS IN ZAMBIA<br />
This annex describes the methodology used to exam<strong>in</strong>e the health <strong>and</strong> economic benefits of<br />
the malaria control efforts made by three large Zambian companies.<br />
BUSINESS INVESTING IN MALARIA CONTROL: ECONOMIC RETURNS AND A HEALTHY WORKFORCE FOR AFRICA<br />
Extensive work was done with f<strong>in</strong>ancial managers<br />
<strong>and</strong> health staff <strong>in</strong> each of the three companies<br />
to compile the data from 2000–2009 required to<br />
conduct the analysis. The companies provided<br />
health services for their employees <strong>and</strong> family<br />
members <strong>and</strong> had ma<strong>in</strong>ta<strong>in</strong>ed good record keep<strong>in</strong>g<br />
of health events <strong>and</strong> of the costs of these events<br />
over that time period. The companies also had<br />
consistent records of production <strong>and</strong> per-employee<br />
production <strong>and</strong> costs <strong>and</strong> profits over this time.<br />
F<strong>in</strong>ally, the companies ma<strong>in</strong>ta<strong>in</strong>ed good records<br />
of their costs for malaria control work <strong>in</strong> staff<br />
homes <strong>and</strong> nearby communities. These records<br />
were reviewed by <strong>in</strong>dependent observers with<br />
the permission <strong>and</strong> support of the companies, <strong>and</strong><br />
summaries were developed for this report.<br />
The three steps mentioned <strong>in</strong> Chapter 3, lead<strong>in</strong>g<br />
to the determ<strong>in</strong>ation of the number of malaria<br />
episodes averted, the medical cost sav<strong>in</strong>gs <strong>and</strong> the<br />
absence sav<strong>in</strong>gs (Figure A.1; same as Figure 2.2) are<br />
described <strong>in</strong> detail <strong>in</strong> this annex. They are essential<br />
steps <strong>in</strong> the calculations needed to determ<strong>in</strong>e the<br />
actual net benefits of malaria control by the private<br />
companies.<br />
Figure A.1<br />
Data collection <strong>and</strong> analysis sequence to exam<strong>in</strong>e bus<strong>in</strong>ess <strong>in</strong>vestment <strong>in</strong> malaria control at Zambia<br />
Sugar, Mopani Copper M<strong>in</strong>es <strong>and</strong> Konkola Copper M<strong>in</strong>es, Zambia, 2001–2009<br />
Basel<strong>in</strong>e<br />
malaria<br />
<strong>in</strong>cidence<br />
<br />
Workforce<br />
Household<br />
size<br />
<br />
Average<br />
absences per<br />
episode<br />
<br />
Average<br />
daily pay<br />
<br />
<br />
<br />
Primary variables<br />
Actual malaria<br />
episodes<br />
<br />
Step I:<br />
<strong>Malaria</strong><br />
episodes<br />
averted<br />
Step II:<br />
Medical cost<br />
sav<strong>in</strong>gs<br />
<br />
Step III:<br />
Absence<br />
sav<strong>in</strong>gs<br />
<br />
<br />
<br />
Share of<br />
<strong>in</strong>- <strong>and</strong><br />
out-patients<br />
<br />
Average cost<br />
of <strong>in</strong>- <strong>and</strong><br />
out-patients<br />
Costs of<br />
malaria<br />
control<br />
Net benefits<br />
of malaria<br />
control<br />
Secondary variables (=calculated)<br />
<br />
46